文献速递眼底病与葡萄膜炎

基线OCT生物标志物预测新生血管性年龄相关性黄斑变性视力结局的Meta分析

Baseline OCT Biomarkers Predicting Visual Outcomes in Neovascular Age-Related Macular Degeneration: A Meta-Analysis.
PubMed 文献 · Ophthalmology · 2025-06-24

该Meta分析纳入29篇报告(8863只眼)评估80种生物标志物,发现低确定性证据支持基线完整的外界膜和椭圆体带预测抗VEGF治疗后12个月较好视力,而视网膜内液、中心凹中心点视网膜内液和视网膜下高反射物质预测较差视力。

要点

  • 基线完整外界膜预测12个月视力提高14.0个ETDRS字母(低确定性)。
  • 基线视网膜内液预测12个月视力降低5.6个ETDRS字母(低确定性)。
  • 基线中心凹中心点视网膜内液预测12个月视力降低7.4个ETDRS字母(低确定性)。

核心结论

  • 低确定性证据表明,基线完整外界膜和椭圆体带预测12个月较好视力,视网膜内液、中心凹中心点视网膜内液和视网膜下高反射物质预测12个月较差视力。
  • 需要改进生物标志物分类的标准化和控制混杂变量。

研究设计与样本

  • Meta分析,纳入29篇报告(8863只眼),评估80种生物标志物。
  • 采用GRADE指南评估预后研究的证据确定性,结果以ETDRS字母报告,并以5字母最小重要差异解释。

主要发现

  • 基线完整外界膜预测12个月视力较好(+14.0;95%CI +3.1至+24.8;低确定性)。
  • 基线完整椭圆体带预测12个月视力较好(+6.8;95%CI +2.8至+10.8;低确定性)。
  • 基线视网膜内液预测12个月视力较差(-5.6;95%CI -9.7至-1.5;低确定性)。
  • 基线中心凹中心点视网膜内液预测12个月视力较差(-7.4;95%CI -10.1至-4.7;低确定性)。
  • 基线视网膜下高反射物质预测12个月视力较差(-8.7;95%CI -19.0至+1.6;低确定性)。

关键数值与推荐

  • 以5字母最小重要差异为阈值,仅上述5种生物标志物的效应量跨过该阈值。
  • 色素上皮脱离、地图样萎缩、视网膜内液合并视网膜下液预测12个月视力降低(相对于0字母阈值有统计学显著性,中等确定性)。
  • 视网膜下液预测12个月视力正向变化(中等确定性)。
  • 无后玻璃体脱离预测12个月视力负向变化(中等确定性)。
  • 中心1mm内视网膜内液、视网膜色素上皮隆起和地图样萎缩预测24个月视力负向变化(中等确定性)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要改进生物标志物分类的标准化和控制混杂变量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

TOPIC: To determine the effect estimates and certainty of evidence for baseline OCT biomarkers predicting visual acuity (VA) and changes in VA from baseline at 6, 12, and 24 months after anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration. CLINICAL RELEVANCE: Understanding the prognostic utility of biomarkers can improve treatment decisions. METHODS: Results were reported in ETDRS letters. Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) guidelines for prognostic studies informed certainty of evidence. Results were interpreted using a 5-letter minimally important difference. RESULTS: Twenty-nine reports (8863 eyes) evaluating 80 biomarkers were included. Two biomarkers predicted better VA at 12 months with a low-certainty: the presence of an intact external limiting membrane (+14.0; 95% confidence interval [CI], +3.1 to +24.8) and the presence of an intact ellipsoid zone (+6.8; 95% CI, +2.8 to +10.8). Three biomarkers predicted worse VA at 12 months with a low certainty; the presence of intraretinal fluid (IRF; -5.6; 95% CI, -9.7 to -1.5), the presence of IRF in the foveal center point (-7.4; 95% CI, -10.1 to -4.7), and the presence of subretinal hyperreflective material (-8.7; 95% CI, -19.0 to 1.6). No other biomarker predicted an effect size that crossed the minimally important difference. However, noteworthy results occurred when interpreting biomarkers with statistically significant findings relative to a threshold of 0 letters and moderate certainty: the presence of a pigment epithelial detachment, geographic atrophy (GA), and both IRF and subretinal fluid (SRF) predicted reduced vision at 12 months. The presence of SRF predicted a positive change in VA at 12 months. The absence of a posterior vitreous detachment predicted a negative change in VA at 12 months. Finally, the presence of IRF in the central 1 mm, retinal pigment epithelial elevation, and GA predicted negative changes in VA at 24 months. DISCUSSION: With low-certainty evidence, the baseline presence of an intact external limiting membrane and ellipsoid zone predicted better VA at 12 months, and the presence of IRF, IRF in the foveal center point, and subretinal hyperreflective material predicted worse VA at 12 months. Improved standardization in biomarker classification and control of confounding variables is needed. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Nanji K, Grad J, Hatamnejad A, et al. Baseline OCT Biomarkers Predicting Visual Outcomes in Neovascular Age-Related Macular Degeneration: A Meta-Analysis. Ophthalmology. 2025. PMID: 40570933. doi:10.1016/j.ophtha.2025.06.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。